Pulse Biosciences touts positive results from PFA early feasibility study
Pulse Biosciences has reported positive results from a first-in-human feasibility study evaluating its nanosecond pulsed field ablation (nsPFA) technology for…
All articles by Robert Barrie
Robert Barrie
Robert Barrie is a trainee reporter for Medical Device Network, covering developments in the healthcare sector. Coming from a scientific and medical background, Robert has reported across various topics with expertise in neuroscience, genetics, and epidemiology. Previously, he worked on a freelance basis with New Scientist.
-
-
CEPI provides $6.2m to push first mRNA-based Rift Valley fever vaccine into trial
South African biotech Afrigen Biologics has secured a $6.2m grant from the Coalition for Epidemic Preparedness Innovations (CEPI) to develop…
-
WHO reports eight deaths from suspected Marburg outbreak in Tanzania
Eight people have likely died from an outbreak of Marburg virus disease (MVD) in a northwestern region of Tanzania, according…
-
JP Morgan 2025: NVIDIA partners with IQVIA, Illumina and Mayo Clinic
In moves that continue to strengthen its affiliation with the healthcare industry, NVIDIA has added three new companies to its…
-
Chugai and Araris enter $780m ADC research collaboration
Chugai Pharmaceutical and Araris Biotech have entered an antibody-drug conjugate (ADC)-focused research collaboration and option-to-license agreement worth up to $780m.…
-
Experts call for a shift from reactive to proactive clinical trial supply frameworks
With supply chain disruptions becoming worse and more frequent over the past decade, moving from a paradigm of reactiveness to…
-
Supply chains too often “last cog” implemented in clinical trials
Placing emphasis on supply chains before initiating a clinical trial can help create protocols that are robust against delays, unlike…
-
“Systematic reviews” for underrepresented groups in trials needed, says WHO senior adviser
Systematic reviews are needed to address gaps in population representation in clinical trials to ensure the quality level of evidence…
-
“Preparation key” to prevent airfreight transit delay of medicines to clinical trials
Airline passenger numbers may have been slow to rise after the Covid-19 pandemic, but air cargo’s rebound was much quicker.…
-
Vaccine clinical trial spotlight on Southeast Asia as “unique” opportunity beckons
Southeast Asia offers a unique opportunity for sponsors conducting clinical trials with vaccine candidates including faster recruitment, lower costs, and…